SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Vijaypd Ceutical Ltd (VIJAYPD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VIJAYPD Trading | Small Cap | Vijaypd Ceutical Share Price

BSE Share Price
Not Listed

Vijaypd Ceutical Ltd (VIJAYPD)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: VIJAYPD Trading | Small Cap | Vijaypd Ceutical Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹161 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹2.6
TTM Sales
₹99 Cr.
Book Value per Share
₹19.3
P/E Ratio
31.79
Higher than its 5-year historical median
Industry PE
36.2
Price to Book (P/B)
4.27
Higher than its 5-year historical median
Price to Sales (P/S)
1.62
Higher than its 5-year historical median
EV/EBITDA
20.51
Higher than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
14.91%
Outperforms industry median
Return on Capital Employed (ROCE)
16.08%
Outperforms industry median
Return on Assets (ROA)
8.40%
Operating Profit Margin
8%
Net Profit Margin
4.49%
Gross Profit Margin
6.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
56.43%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹32 Cr.
Equity
₹19.5 Cr.
Face Value
₹10
All Time Low / High
- / -

Vijaypd Ceutical stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Locked
Login to view analysis.

Valuation

Locked
Login to view analysis.

Price Trend

Locked
Login to view analysis.
Q.1 Is Vijaypd Ceutical Ltd a good quality company?
Vijaypd Ceutical Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Vijaypd Ceutical Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Vijaypd Ceutical Ltd vs industry peers?
Vijaypd Ceutical Ltd revenue CAGR is %, compared to the industry median CAGR of 6.81%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Vijaypd Ceutical Ltd?
Promoters hold 56.43% of the Vijaypd Ceutical Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Vijaypd Ceutical Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
View More

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vijaypd Ceutical Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'25TTM
ROCE % ⓘ16.1%-
Value Creation
Index ⓘ		0.2-

Growth Parameters ⓘ
Sales ⓘ10799
Sales YoY Gr.--
Adj EPS ⓘ3.42.6
YoY Gr.--
BVPS (₹) ⓘ22.919.3
Adj Net
Profit ⓘ		4.85
Cash Flow from Ops. ⓘ-7.9-
Debt/CF from Ops. ⓘ-2.8-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNANANANA
Adj EPS ⓘNANANANA
BVPSⓘNANANANA
Share Price - - - -

Key Financial Parameters ⓘ

Mar'25TTM
Return on
Equity % ⓘ		14.912.3
Op. Profit
Mgn % ⓘ		8NAN
Net Profit
Mgn % ⓘ		4.55.1
Debt to
Equity ⓘ		0.7-
Working Cap
Days ⓘ		00
Cash Conv.
Cycle ⓘ		00

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'25
Sales107
Operating Expenses ⓘ + 98
Manufacturing Costs0
Material Costs89
Employee Cost 2
Other Costs ⓘ 8
Operating Profit ⓘ 9
Operating Profit Margin (%) 8.0%
Other Income ⓘ + 1
Exceptional Items ⓘ 0
Interest ⓘ 2
Depreciation ⓘ 1
Profit Before Tax ⓘ 7
Tax ⓘ 2
Profit After Tax 5
PAT Margin (%) 4.5%
Adjusted EPS (₹)3.4
Dividend Payout Ratio (%)0%

Valuation of Vijaypd Ceutical - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'25

Equity and Liabilities

Shareholders Fund + 32
Share Capital ⓘ 14
Reserves ⓘ 18
Debt +21
Long Term Debt0
Short Term Debt21
Minority Interest0
Trade Payables2
Others Liabilities ⓘ 2
Total Liabilities ⓘ 57

Fixed Assets

Net Fixed Assets ⓘ +8
Gross Block11
Accumulated Depreciation2
CWIP ⓘ 0
Investments ⓘ 0
Inventories12
Trade Receivables24
Cash Equivalents 3
Others Assets ⓘ 10
Total Assets ⓘ 57

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'25
Cash Flow From Operating Activity ⓘ + -8
PBT ⓘ 7
Adjustment ⓘ 3
Changes in Working Capital ⓘ -16
Tax Paid ⓘ -1
Cash Flow From Investing Activity ⓘ + -1
Capex -1
Net Investments 0
Others ⓘ 0
Cash Flow From Financing Activity ⓘ + -2
Net Proceeds from Shares ⓘ 0
Net Proceeds from Borrowing ⓘ -1
Interest Paid ⓘ -2
Dividend Paid ⓘ 0
Others ⓘ 1
Net Cash Flow ⓘ -11

Financial Ratio

PARTICULARSMar'25
Ratios
ROE (%)14.91
ROCE (%)16.08
Asset Turnover Ratio1.87
PAT to CFO Conversion(x)-1.6
Working Capital Days
Receivable Days81.30
Inventory Days39.40
Payable Days8.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Vijaypd Ceutical Ltd FAQs

The current trading price of Vijaypd Ceutical on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Vijaypd Ceutical stood at ₹160.7 Cr

The latest P/E ratio of Vijaypd Ceutical as of 31-Dec-1969 is 31.79.

The latest P/B ratio of Vijaypd Ceutical as of 31-Dec-1969 is 4.27.

The 52-week high of Vijaypd Ceutical is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vijaypd Ceutical is ₹98.96 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Vijaypd Ceutical Ltd is a below average quality company.

The key valuation ratios of Vijaypd Ceutical Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Vijaypd Ceutical Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Vijaypd Ceutical Ltd

Vijaypd Ceutical was originally formed as a partnership firm under the name and style of ‘M/s. Vijay Pharma’ pursuant to a deed of partnership dated October 05, 1971. Further, M/s. Vijay Pharma was converted into a public limited company ‘Vijaypd Ceutical Limited’ on March 19, 2024. Further, the company has acquired the running business of M/s. P.D. Doshi, a Partnership firm on going concern basis vide Business Transfer Agreement dated April 1, 2024.

The company is engaged in the business of distribution and supply within the pharmaceutical and consumer goods sectors, offering a comprehensive range of services. Its roles include being representatives, dealers, agents, stockists, suppliers, traders, and packers. It offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the fastmoving consumer goods (FMCG) market. Its pharmaceutical and wellness product range includes medicines such as injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, and liquid oral formulations. It also supplies vitamins, hormones, enzymes, wellness tonics, serums, and diagnostic test kits. In the FMCG segment, it provides personal care and toiletry products, including soaps, sanitizers, and baby care items. Additionally, it deals in ayurvedic products, cosmetics, food products, dental products, and crude drugs.

The company is positioning itself to expand its market presence by diversifying into the manufacturing of active pharmaceutical ingredient (APIs) which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula (FDF) such as tablet, capsules, ointment, syrup etc, and excipients. Further, the company as a pharmaceutical distributor, holds certifications from the Food and Drug Administration (FDA), the Food Safety and Standards Authority of India (FSSAI), and the competent authorities of the Brihanmumbai Municipal Corporation (BMC). These certifications help maintain the integrity of pharmaceutical products throughout storage, handling, and transportation, while also enhancing operational efficiency and quality control.

Business area of the company 

The company is engaged in the business of wholesale Distribution of Pharmaceutical products. It offers a wide range of products serving both the pharmaceutical and wellness industries, as well as the FMCG market.

Services provided by the company

  • Healthcare products distribution: The company provides distribution and logistics services for healthcare products to retail pharmacies, nursing homes and healthcare clinics.
  • Retail distribution: The company’s retail distribution channel involves distributing healthcare products to pharmacies, who then sell these products to end customers.
  • Distribution to Clinics, Doctors and Nursing Homes: The company supplies a wide range of healthcare products, including pharmaceutical and nutraceutical products, to nursing homes and clinics through its nationwide distribution network, which consists of its delivery fleet, delivery personnel and local logistics.
  • Supply chain and distribution platform: The company serves the customers (including pharmacies, nursing homes and healthcare clinics) through a diverse network of distribution through warehouses. 

Awards, accreditations and recognition 

  • 1999: Received Award from the Pharmaceutical Wholesale’s Association (Mumbai) for Recognition and Sincere Appreciation of distinguished and devoted service rendered in Pharmaceutical Distribution Over 25 Years.
  • 2015: Received Award for Securing 3rd Rank in Maharashtra for the Sale Turnover of Cipla FY 2014-15.
  • 2016: Received Award from Cipla for Outstanding Contribution and Continued Association, 25 Years of Trust.
  • 2017: Received Award towards contribution in making affordable medicines reach out to millions of patients and grow GSK Business.
  • 2018: Received Award for GSK National Channel Partner Recognition amongst top contributing pharmaceutical distribution across India for GSK Pharmaceutical Limited.

History and milestones

  • 1971: Formed as a Partnership Firm in the name and style of ‘M/s. Vijay Pharma’.
  • 2024: Conversion of Partnership Firm into Public Limited Company in the name and style of ‘Vijaypd Ceutical Limited’.
  • 2024: The company has acquired the running business of ‘M/s. P.D. Doshi’, a Partnership firm on Going Concern basis.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×